Menveo
Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine · Injection, Solution · Intramuscular
No FDA structured label text is available for Menveo. The NDC listings below come from the FDA National Drug Code directory.
Active ingredients
- Neisseria Meningitidis Group A Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen in 1 product
- Neisseria Meningitidis Group C Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen in 1 product
- Neisseria Meningitidis Group W-135 Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen in 1 product
- Neisseria Meningitidis Group Y Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen in 1 product
Menveo NDC products (2)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 58160-827 | Neisseria Meningitidis Group A Capsular Oligosaccharide Diphtheria Crm197 Protein Conjugate Antigen 10 ug/.5mL;… Injection, Solution | GlaxoSmithKline Biologicals SA | BLA |
| 58160-955 | Kit | GlaxoSmithKline Biologicals SA | BLA |
Frequently asked questions
Who makes Menveo?
Menveo is listed by 1 labeler in the FDA NDC directory, including GlaxoSmithKline Biologicals SA.